In Drosophila, the tinman homeobox gene is absolutely required for heart development. In the vertebrates, a small family of tinman-related genes, the cardiac NK-2 genes, appear to play a similar role in the formation of the vertebrate heart. However, targeted gene ablation of one of these genes, Nkx2-5, results in defects in only the late stages of cardiac development suggesting the presence of a rescuing gene function early in development. Here, we report the characterization of a novel tinman-related gene, XNkx2-10, which is expressed during early heart development in Xenopus. Using in vitro assays, we show that XNkx2-10 is capable of transactivating expression from promoters previously shown to be activated by other tinman-related genes, including Nkx2-5. Furthermore, Xenopus Nkx2-10 can synergize with the GATA-4 and SRF transcription factors to activate reporter gene expression. q
Results and discussion
Somewhat unexpectedly, mice lacking Nkx2-5 function are able to form beating heart tissue and the majority of myocardial differentiation markers are expressed normally (Lyons et al., 1995) . This result suggests that additional tinman-related genes expressed in the developing heart may partially substitute for Nkx2-5 function in the knock-out mouse (Lyons et al., 1995) . Using low stringency screening we have identi®ed XNkx2-10, a new member of the vertebrate tinman-related gene family (Fig. 1A) . The XNkx2-10 protein is 263 amino acids long, shorter than the Xenopus homologues of XNkx2-3 (338 amino acids) and XNkx2-5 (299 amino acids) and closer in length to the zebra®sh nkx2-7 coding region (267 amino acids). The XNkx2-10 homeodomain sequence differs from all previously described Tinman-related proteins (Fig. 1B) . Speci®cally, the methionine and glutamine residues located at homeodomain positions 11 and 15, respectively, are not present in any other Tinman family proteins (Harvey, 1996) . Indeed, the XNkx2-10 homeodomain differs at ten positions from chicken cNkx2-8, at nine positions from XNkx2-5, at six positions from XNkx2-3 and at ®ve positions from zebra®sh Nkx2-7. Outside of the homeodomain, XNkx2-10 contains both a TN domain and an NK-2 Speci®c Domain related to those in other Tinman-family proteins. The primary sequence therefore suggests that XNkx2-10 is a novel member of the vertebrate tinman gene family.
By RNase protection assay (Fig. 1C ) XNkx2-10 is ®rst transcribed in the early neurula stage embryo. This is later than the onset of XNkx2-5 expression which occurs at the mid-gastrula stage in Xenopus . By whole-mount in situ hybridization, early expression of XNkx2-10 closely resembles that of XNkx2-3 and XNkx2-5. XNkx2-10 transcripts are ®rst visible at the late neurula stage in a position consistent with the location of precardiac tissue ( Fig. 2A) . By the early tailbud stage, cardiac precursor cells and also the overlying anterior pharyngeal endoderm are XNkx2-10 positive (Fig. 2B,C,F,G) . At stage 28, myocardial precursor cells initiate the expression of cardiac differentiation markers (Chambers et al., 1994; Drysdale et al., 1994) . It is at this stage, that XNkx2-10 expression begins to decrease in the forming myocardium (Fig. 2D,H) . In contrast, both XNkx2-3 and XNkx2-5 transcripts remain abundant in the developing heart throughout embryonic development (Fig. 2E,K) Evans et al., 1995; Cleaver et al., 1996) . Whereas cardiac expression of XNkx2-10 decreases in the mid-tailbud stage embryo, transcripts remain extremely abundant in the pharyngeal endoderm (Fig. 2D,E) . XNkx2-10 expression decreases in the pharyngeal endoderm and becomes undetectable by the late tadpole stage (stage 42). PCR analysis fails to detect Nkx2-10 expression in any adult tissue tested (heart, spleen, kidney, liver, lung, pancreas and skeletal muscle).
We have carried out preliminary experiments to determine the transcription regulating properties of Nkx2-10. First, we tested for transactivating ability by co-transfecting variable amounts of a plasmid containing XNkx2-10 sequences, together with the 3£ (A20)-TATA-LUC construct (Chen and Schwartz, 1996) , into the CV-1 cultured cell line. In parallel experiments, XNkx2-10 sequences were co-transfected with the minimal cardiac actin promoter construction. As shown in Fig. 3A , low levels of XNkx2-10 produce little effect, but higher levels cause a signi®cant increase in reporter gene activity over background. In the case of 3£ (A20)-TATA-LUC a 14-fold increase is observed and for Ca SRE1-TATA-LUC the stimulation is 7-fold. The ability of XNkx2-10 to co-operate with other transcription factors was also tested. As shown in Fig. 3B , transfection of 150 ng of XNkx2-10 plasmid alone, results in a less than 2-fold increase in Ca SRE1-TATA-LUC reporter gene activity, and transfection with the MADS class transcription factor, SRF, results in a 6-fold increase in luciferase activity (Fig. 3B) . However, co-transfection of both XNkx2-10 and SRF leads to a 17-fold activation of luciferase activity. Similarly, expression of GATA4 alone results in only a slight increase in luciferase activity, while co-transfection of both GATA4 and XNkx2-10 leads to a 4-fold increase (Fig. 3B) . These studies indicate that XNkx2-10 functions as a weak transcriptional activator and this activity is synergized by cooperation with other cardiac-expressed transcription factors. Overall, Nkx2-10 is a weaker activator than Nkx2-5, but approximately equivalent to Nkx2-8 when tested in identical assays. For comparison, Nkx2-5 cotransfection with GATA-4 increases Ca SRE1-TATA-LUC reporter activity approximately 15-fold while Nkx2-8 plus GATA-4 results in an approximately 2-fold increase (Sepulveda et al., 1998 ).
We have also tested the effects of XNkx2-10 expression in the Xenopus embryo. Although previous studies indicate that over-expression of either Nkx2-3 or Nkx2-5 in the Xenopus embryo results in enlarged hearts (Chen et al., 1996; Cleaver et al., 1996) , we have been unable to replicate this effect using Nkx2-10. Although one must be cautious with the interpretation of negative results, these experiments suggest that the biological activities of Nkx2-5 and Nkx2-10 are not identical. Newman and Krieg (1998) , where the gene was called Nkx2-9. The conserved TN, homeo-and NK-2 Speci®c domains are highlighted by overlines, underlines and dash underlines respectively. The GenBank accession number is AF127224. (B) Comparison the homeodomain sequences of cardiac NK-2 genes from frog, chick and zebra®sh Evans et al., 1995; Lee et al., 1996; Boettger et al., 1997; Brand et al., 1997; Reecy et al., 1997) . (C) RNase protection assay to determine the onset of XNkx2-10 gene expression. RNA samples from early (stage 10.5) and late (stage 12) gastrula and early (stage 14) and late (stage 19) neurula were assayed. The XNkx2-10 probe consisted of the ®nal 310 nt of the coding region. The ubiquitous Xmax gene (Tonissen and ) is used as a loading control.
Experimental procedures
Approximately 10 6 plaques of a Xenopus stage 42 tadpole cDNA library were screened at low stringency with the coding region of the chicken cNkx2-8 gene. All ®lters were washed in 5£ SSC/0.1% SDS at 378C. RNase Note the lack of XNkx2-10 expression in the folded heart (small arrowhead) and the lack of XNkx2-5 expression in the pharyngeal endoderm (large arrowhead). Arrows highlight expression of both XNkx2-5 and XNkx2-10 in the mesoderm immediately dorsal to the heart. In situ analysis was performed as described by Harland (1991) .
protection analysis was performed as described by Krieg and Melton (1987) using ten embryo equivalents of total RNA. For transcription studies, CV-1 ®broblasts were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% fetal bovine serum. Proliferating CV-1 ®broblasts were transfected using Lipofectamine (Gibco), with a total of 2.5 mg of DNA, consisting of 3£ (A20)-TATA-LUC or Ca SRE1-TATA-LUC (1 mg; Chen and Schwartz, 1995; Chen et al., 1996) in the presence or absence of pCS2-XNkx2-10 and/or pCGN-SRF (150 ng, gift of Dr. Ron Prywes). All transfections were balanced for a constant amount of pCGN control vector. After 6 h at 378C, 3 ml of DMEM containing 3% horse serum and 15 mg/ml of insulin was added to the transfected cells, which were then incubated for an additional 60 h. Cells were washed with phosphate buffered saline and lysed with 400 ml of Reporter Lysis Buffer (Promega). Lysates were analyzed for luciferase activity as described previously (Reecy et al., 1997) . 
